企業プロフィール
IGC Pharma, Inc. 株価・ニュース・カタリスト
- ティッカー:
- IGC
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.28 USD (-5.98%)
終値
最終更新: 2026年8月17日
29M USD
時価総額
株価変動の要因
As of Aug 17, 2026, IGC closed down 5.98% at $0.2800. No new same-company headline was identified in the current news window.
企業概要
事業概要
IGC Pharma is a biopharmaceutical company exploring cannabinoid-based and other therapeutic programs, including neuropsychiatric and metabolic concepts. Its identity has been tied to a broad but still early-stage development story.
所在地とセクター分類
IGC Pharma is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotech with a neuropsychiatry and cannabinoid angle.
ビジネスモデルの特徴
The company depends on early development work, regulatory pathfinding, and capital efficiency. Investors typically watch program updates, preclinical or early clinical signals, and whether the company can sharpen its focus.
バイオ業界での位置付け
IGC occupies a speculative small-cap biotechnology niche. It is more of an early-stage concept story than a mature clinical platform.
今後のカタリスト
- IGC Pharma’s catalysts are its cannabis-derived and neuro-related programs, plus any operating update that clarifies commercial progress. The market will care about whether the company can turn the platform into a real business.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。